⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uracil SCHEMBL11607890 | 0.97 | — | — | |
| Uracil SCHEMBL5089507 | 0.97 | — | — | |
| Uracil SCHEMBL3798527 | 0.97 | CRBN (1.00) | — | |
| Uracil SCHEMBL8235 | 0.97 | — | — | |
| Uracil SCHEMBL18010636 | 0.94 | — | — | |
| Uracil SCHEMBL2557975 | 0.94 | — | — | |
| Uracil SCHEMBL228901 | 0.94 | — | — | |
| Uracil SCHEMBL3165194 | 0.94 | — | — | |
| Uracil SCHEMBL21385227 | 0.94 | — | — | |
| Uracil SCHEMBL710130 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117658936-A | Synthesis method of 3,5, 6-trichloro- [1,2,4] -thiazine | 上海予君生物科技发展有限公司 | 2024-03-08 | — | — | CN | claimed |
| CN-121951537-A | Low-angle aluminum etching liquid composition | 润晶(合肥)光电材料有限公司 | 2026-05-01 | — | — | CN | disclosed |
| US-20260085051-A1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | ADAMA AGAN LTD. (IL) | 2026-03-26 | — | — | US | disclosed |
| CN-121045095-A | Synthesis method of 6- (difluoromethyl) -2 hydrogen-1, 2, 4-triazabenzene-3, 5-dione | 都创(上海)医药开发有限公司 | 2025-12-02 | — | — | CN | disclosed |
| EP-4313954-B1 | PREPARATION OF 2-CHLORO-4-FLUORO-5-NITROBENZOIC ACID | ADAMA AGAN LTD (IL) | 2025-10-15 | — | — | EP | disclosed |
| CN-110787285-B | XBP1, CD138 and CS1 peptides, pharmaceutical compositions comprising the peptides, and methods of using the peptides and compositions | 达纳-法伯癌症研究所股份有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-119192383-A | ENTPD2 antibodies, combination therapies, and methods of using these antibodies and combination therapies | 诺华股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-118994397-A | Trispecific binding molecules directed against BCMA and uses thereof | 诺华股份有限公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-118974097-A | Anti-PSMA antibodies, variants thereof, and uses thereof | 西安奥瑞单抗生物技术有限公司 | 2024-11-15 | — | — | CN | disclosed |
| CN-110799640-B | T cells expressing chimeric antigen receptors | 综合医院公司 | 2024-11-12 | — | — | CN | disclosed |
| WO-2015090230-A1 | HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF | NOVARTIS AG (CH) | 2015-06-25 | — | — | WO | disclosed |
| CN-104203985-A | Cyclodextrin-based polymers for therapeutic delivery | CERULEAN PHARMA INC | 2014-12-10 | — | — | CN | disclosed |
| WO-2014078374-A2 | METHODS FOR MULTIPLEXED DRUG EVALUATION | PRESAGE BIOSCIENCES, INC. (US) | 2014-05-22 | — | — | WO | disclosed |
| WO-2014071402-A1 | XBP1, CD138, AND CS1, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE PEPTIDES, AND METHODS OF USING SUCH PETIDES AND COMPOSITIONS | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2014-05-08 | — | — | WO | disclosed |
| US-20140099263-A1 | POLYMER-AGENT CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE | CERULEAN PHARMA INC. (US) | 2014-04-10 | — | — | US | disclosed |
| CN-103037903-A | Compositions and methods for treating autoimmune or other diseases | CERULEAN PHARMA INC | 2013-04-10 | — | — | CN | disclosed |
| CN-102666533-A | TREATMENT OF CANCER | CERULEAN PHARMA INC | 2012-09-12 | — | — | CN | disclosed |
| CN-102378626-A | Polymer-agent conjugates, particles, compositions, and related methods of use | CERULEAN PHARMA INC | 2012-03-14 | — | — | CN | disclosed |
| US-20110028496-A1 | Deuterium-enriched pyrimidine compounds and derivatives | DHANOA DALJIT SINGH | 2011-02-03 | — | — | US | disclosed |
| US-4474762-A | Antibiotic compounds, their production and their medicinal use | BAYER AKTIENGESELLSCHAFT (DE) | 1984-10-02 | — | — | US | disclosed |